Abstract
In the US, whistle blowers who help uncover illegal offlabel promotion are usually awarded 15-25 percent of any recovered damages. Does incentivizing informants deter off-label drug marketing – and should other countries follow suit?
| Original language | English |
|---|---|
| Pages | 503-506 |
| Specialist publication | The Medicine Maker |
| Publication status | Published - 2016 Feb 3 |
Subject classification (UKÄ)
- Sociology (excluding Social Work, Social Psychology and Social Anthropology)
- Health Care Service and Management, Health Policy and Services and Health Economy
